HomeNDC LookupRxCUI directory › RxCUI 283858

Ropinirole 3 MG Oral Tablet — RxCUI 283858

RxNorm drug concept · Semantic clinical drug
RxCUI 283858 Semantic clinical drug · SCD ● Current RxNorm concept 57 FDA products 83 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI283858
Official nameRopinirole 3 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asropinirole 3 MG (as ropinirole hydrochloride) Oral Tablet; rOPINIRole HCl 3 MG Oral Tablet
FDA products mapped57
Package NDCs mapped83
Reported Medicaid activity (SDUD)623,265 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ropinirole: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ropinirole treats two different conditions. The regular tablets are approved for Parkinson's disease and for moderate-to-severe Restless Legs Syndrome — that uncomfortable, irresis...
  • Yes, and it's one of the most important things to know. Some people taking ropinirole have fallen asleep suddenly during everyday activities — including while driving — sometimes w...
  • I heard this medication can make you fall asleep out of nowhere. Is that true?
  • It can, and this is something to watch for carefully. Some people develop strong, hard-to-control urges — like gambling, overeating, compulsive shopping, or increased sexual intere...
📖 Read our full Ropinirole guide →

🕸️ Concept Web — How Ropinirole 3 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ropinirole 3 MG Oral Tablet RxCUI 283858

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ropinirole 72302
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ropinirole Oral Tablet 373800
    • Ropinirole Oral Product 1157983
    • Ropinirole Pill 1157984
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Ropinirole 3 MG 334368

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ropinirole 3 MG SCDC · 334368
  • Ropinirole Oral Tablet SCDF · 373800
  • Ropinirole Oral Product SCDG · 1157983
  • Ropinirole Pill SCDG · 1157984

📦 FDA Products & Package NDCs

57 products · 83 package NDCs
83 package NDCs map to RxCUI 283858 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
62332-0031-31 100 TABLET, FILM COATED in 1 BOTTLE (62332-031-31) ROPINIROLE Alembic Pharmaceuticals Inc. 2016-01-29
62332-0032-31 100 TABLET, FILM COATED in 1 BOTTLE (62332-032-31) ROPINIROLE Alembic Pharmaceuticals Inc. 2016-01-29
62332-0033-31 100 TABLET, FILM COATED in 1 BOTTLE (62332-033-31) ROPINIROLE Alembic Pharmaceuticals Inc. 2016-01-29
62332-0034-31 100 TABLET, FILM COATED in 1 BOTTLE (62332-034-31) ROPINIROLE Alembic Pharmaceuticals Inc. 2016-01-29
62332-0035-31 100 TABLET, FILM COATED in 1 BOTTLE (62332-035-31) ROPINIROLE Alembic Pharmaceuticals Inc. 2016-01-29
62332-0036-31 100 TABLET, FILM COATED in 1 BOTTLE (62332-036-31) ROPINIROLE Alembic Pharmaceuticals Inc. 2016-01-29
67046-1490-03 30 TABLET, FILM COATED in 1 BLISTER PACK (67046-1490-3) ROPINIROLE Coupler LLC 2025-01-29
68462-0253-01 100 TABLET, FILM COATED in 1 BOTTLE (68462-253-01) ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0253-10 1000 TABLET, FILM COATED in 1 BOTTLE (68462-253-10) ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0253-11 10 BLISTER PACK in 1 CARTON (68462-253-11) / 10 TABLET, FIL... ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0254-01 100 TABLET, FILM COATED in 1 BOTTLE (68462-254-01) ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0254-10 1000 TABLET, FILM COATED in 1 BOTTLE (68462-254-10) ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0254-11 10 BLISTER PACK in 1 CARTON (68462-254-11) / 10 TABLET, FIL... ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0255-01 100 TABLET, FILM COATED in 1 BOTTLE (68462-255-01) ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0255-10 1000 TABLET, FILM COATED in 1 BOTTLE (68462-255-10) ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0255-11 10 BLISTER PACK in 1 CARTON (68462-255-11) / 10 TABLET, FIL... ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0256-01 100 TABLET, FILM COATED in 1 BOTTLE (68462-256-01) ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0256-10 1000 TABLET, FILM COATED in 1 BOTTLE (68462-256-10) ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0256-11 10 BLISTER PACK in 1 CARTON (68462-256-11) / 10 TABLET, FIL... ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0257-01 100 TABLET, FILM COATED in 1 BOTTLE (68462-257-01) ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0257-10 1000 TABLET, FILM COATED in 1 BOTTLE (68462-257-10) ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0258-01 100 TABLET, FILM COATED in 1 BOTTLE (68462-258-01) ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0258-10 1000 TABLET, FILM COATED in 1 BOTTLE (68462-258-10) ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0259-01 100 TABLET, FILM COATED in 1 BOTTLE (68462-259-01) ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0259-10 1000 TABLET, FILM COATED in 1 BOTTLE (68462-259-10) ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
68462-0259-11 10 BLISTER PACK in 1 CARTON (68462-259-11) / 10 TABLET, FIL... ropinirole Glenmark Pharmaceuticals Inc., USA 2010-02-25
69452-0356-20 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69452-356-20) Ropinirole Bionpharma Inc. 2022-09-15
69452-0357-20 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69452-357-20) Ropinirole Bionpharma Inc. 2022-09-15
69452-0358-20 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69452-358-20) Ropinirole Bionpharma Inc. 2022-09-15
69452-0359-20 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69452-359-20) Ropinirole Bionpharma Inc. 2022-09-15
69452-0360-20 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69452-360-20) Ropinirole Bionpharma Inc. 2022-09-15
69452-0361-20 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69452-361-20) Ropinirole Bionpharma Inc. 2022-09-15
69452-0362-20 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69452-362-20) Ropinirole Bionpharma Inc. 2022-09-15
Observed labelers: SOLCO HEALTHCARE US, LLC (28) · Glenmark Pharmaceuticals Inc., USA (19) · Accord Healthcare Inc. (7) · Alembic Pharmaceuticals Inc. (7) · Alembic Pharmaceuticals Limited (7) · Bionpharma Inc. (7) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.